PofoliaShared via Pofolia

Cellular Physiology and Biochemistry· 2013Q3

Characteristics of the Cholecystokinin-Induced Depolarization of Pacemaking Activity in Cultured Interstitial Cells of Cajal from Murine Small Intestine

Jae Hwa Lee, Sung-Young Kim, Young Kyu Kwon, Byung Joo Kim et al.

Short summary

Cholecystokinin (CCK) depolarizes and reduces the amplitude of pacemaker potentials in cultured mouse intestinal cells (ICCs) via a CCK1 receptor and TRPC5 channel mechanism.

AI-generated from the title and abstract; the full text is not read.

Key points

  • CCK (100 nM-5 µM) depolarized resting membrane potentials and decreased pacemaker potential amplitudes in cultured ICCs.
  • The CCK1 receptor agonist depolarized ICCs, while the CCK2 receptor agonist had no effect.
  • CCK's effects were blocked by CCK1 antagonists and inhibitors of G-protein, PLC, PKC, and PKA.
  • The TRPC5 ion channel was identified as a key component in CCK-activated currents.

AI-generated from the title and abstract; the full text is not read.

Abstract

BACKGROUND/AIMS: In this study, we studied the effects of cholecystokinin (CCK) on pacemaker potentials in cultured interstitial cells of Cajal (ICCs) from mouse small intestine using the whole cell patch clamp technique. METHODS: ICCs are pacemaker cells that exhibit periodic spontaneous depolarization, which is responsible for the production of slow waves in gastrointestinal smooth muscle, and generate periodic pacemaker potentials in current-clamp mode. RESULTS: Exposure to CCK (100 nM-5 µM) decreased the amplitudes of pacemaker potentials and depolarized resting membrane potentials. To identify the type of CCK receptors involved in ICCs, we examined the effects of CCK agonists and found that the addition of CCK1 agonist (A-71323, 1 µM) depolarized resting membrane potentials, whereas exposure to CCK2 agonist (gastrin, 1 µM) had no effect on pacemaker potentials. To confirm these results, we examined the effects of CCK antagonists and found that pretreatment with CCK1 antagonist (SR 27897, 1 µM) blocked CCK-induced effects. However, pretreatment with CCK2 antagonist (LY 225910, 1 µM) did not. Furthermore, intracellular GDPβS suppressed CCK-induced effects. To investigate the involvements of phospholipase C (PLC), protein kinase C (PKC), and protein kinase A (PKA) in the effects of CCK in cultured ICCs, we used U-73122 (an active PLC inhibitor), chelerythrine (a PKC inhibitor), SQ-22536 (an inhibitor of adenylate cyclase), or mPKAI (an inhibitor of myristoylated PKA). All inhibitors blocked the CCK-mediated effects on pacemaker potentials. In addition, we found that transient receptor potential classical 5 (TRPC5) channel was involved in CCK-activated currents in cultured ICCs. CONCLUSION: These results suggest that the CCK induced depolarization of pacemaking activity occurs in a G-protein-, PLC-, PKC-, and PKA-dependent manner via CCK1 receptor and TRPC5 channel is a candidate for CCK-activated currents in cultured ICCs in murine small intestine. Therefore, the ICCs are targets for CCK and their interaction can affect intestinal motility.

The authors' abstract, as published at the source. Cellular Physiology and Biochemistry, 2013 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Cellular and Molecular Neuroscience

Cellular and Molecular NeuroscienceNeuroscience